Niraparib and Temozolomide in Patients Glioblastoma

NCT06258018 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Glioma, Malignant

Interventions

DRUG: Temodal
DRUG: Niraparib

Sponsor

Armando Santoro, MD

Collaborators

[object Object]
[object Object]